✦ LIBER ✦

Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation

✍ Scribed by Lee, June Koo; Kim, Tae Min; Koh, Youngil; Lee, Se-Hoon; Kim, Dong-Wan; Jeon, Yoon-Kyung; Chung, Doo Hyun; Yang, Seok-Chul; Kim, Young Tae; Kim, Young-Whan; Heo, Dae Seog; Bang, Yung-Jue

Book ID: 119320811
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 359 KB
Volume: 77
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2012.04.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Somatic EGFR mutations and efficacy of t

Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC

✍ Linardou, Helena; Dahabreh, Issa J.; Bafaloukos, Dimitrios; Kosmidis, Paris; Mur 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 759 KB

The use of first-generation tyrosine kin

The use of first-generation tyrosine kinase inhibitors in patients with NSCLC and somatic EGFR mutations

✍ Riely, Gregory J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 153 KB

9162 EGFR, KRAS, PIK3CA mutations and re

9162 EGFR, KRAS, PIK3CA mutations and response to tyrosine kinase inhibitors (TKIs) in advanced NSCLC patients

✍ Chiari, R.; Ludovini, V.; Bianconi, F.; Pistola, L.; Colella, R.; Mameli, M.; Gi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

EGFR mutations in squamous NSCLC – Preva

EGFR mutations in squamous NSCLC – Prevalence and treatment results with EGFR tyrosine kinase inhibitors (TKIs) in patients from western Slovakia

✍ Berzinec, P.; Hlinkova, K.; Copakova, L.; Konecny, M.; Zavodna, K.; Cerna, M.; C 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Coexistence of EGFR mutation and ALK tra

Coexistence of EGFR mutation and ALK translocation in NSCLC: Literature review and case report of response to gefitinib

✍ Santelmo, C.; Ravaioli, A.; Barzotti, E.; Papi, M.; Poggi, B.; Drudi, F.; Mangia 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 370 KB

128PD EGFR, KRAS, PIK3CA MUTATIONS AND R

128PD EGFR, KRAS, PIK3CA MUTATIONS AND RESPONSE TO TYROSINE KINASE INHIBITORS (TKIS) IN ADVANCED NSCLC PATIENTS

✍ Crinò, L.; Pistola, L.; Bianconi, F.; Chiari, R.; Meacci, M.; Colella, R.; Giuff 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 40 KB